Pharming PHAR
NASDAQ PHAR
$10.01 -0.51 (-4.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pharming (PHAR) Short term Debt (2019 - 2022)

Updated

Pharming's Short term Debt was $143,000 in Q3 2022, down 5.9% from the prior quarter.

Analysis

Pharming (PHAR) Short term Debt (2019 - 2022) Analysis & Trends

At the end of FY2021, Short term Debt at Pharming came in at $165,000, down 99.3% from FY2020.

  • In earlier years, Short term Debt was $25 million in FY2020 (+25.0%) and $20 million in FY2019.
  • The Q3 2022 figure marks the lowest quarterly Short term Debt since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Pharming 738.17 Mn -91.99 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 143,000.00
Jun 30, 2022 152,000.00
Mar 31, 2022 162,000.00
Jun 30, 2021 189,000.00
Mar 31, 2021 25,103.00
Dec 31, 2020 24.27 Mn
Dec 31, 2019 19.74 Mn
API Access

Pharming Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEY